#BnAB - Twitter Hashtag

3 months ago

#CROI2026: Low levels of #bNAbs detected in rectal tissue up to 46 weeks post infusion: https://t.co/rsWjnALHIb Researchers say this shows the importance of including tissue sampling in cure-related #bNAb studies. #HIV #HIVcure #HIVresearch #HIVtreatment #HIVscience

HIViBase's tweet photo. #CROI2026: Low levels of #bNAbs detected in rectal tissue up to 46 weeks post infusion:

https://t.co/rsWjnALHIb

Researchers say this shows the importance of including tissue sampling in cure-related #bNAb studies.

#HIV #HIVcure #HIVresearch #HIVtreatment #HIVscience https://t.co/mmjckMXGNG

0

2

1

0

377

Journal of the IAS @jiasociety

5 months ago

JIAS marks #HIVVaccineAwarenessDay with a new viewpoint, “How Vaccinating People Living With #HIV May Guide #bNAb‑Based Vaccines”. Read it now and share: https://t.co/hdnRwvO29Q #HVAD #HVAD2026 #RethinkRebuildRise

jiasociety's tweet photo. JIAS marks #HIVVaccineAwarenessDay with a new viewpoint, “How Vaccinating People Living With #HIV May Guide #bNAb‑Based Vaccines”.

Read it now and share: https://t.co/hdnRwvO29Q

#HVAD #HVAD2026 #RethinkRebuildRise https://t.co/OFhWB36aML

0

5

4

0

603

IAS - the International AIDS Society

@iasociety

5 months ago

📰 @jiasociety has published a special #HIVVaccineAwarenessDay viewpoint calling for the inclusion of people living with #HIV in #bNAb vaccine trials. Read, share & join us in supporting inclusive vaccine research 👉 https://t.co/z2k3hrVSeS #HVAD #HVAD2026 #RethinkRebuildRise

iasociety's tweet photo. 📰 @jiasociety has published a special #HIVVaccineAwarenessDay viewpoint calling for the inclusion of people living with #HIV in #bNAb vaccine trials.

Read, share & join us in supporting inclusive vaccine research 👉 https://t.co/z2k3hrVSeS

#HVAD #HVAD2026 #RethinkRebuildRise https://t.co/hvffeEWBTB

0

13

4

0

996

CAPRISA @CAPRISAOfficial

11 months ago

Head of HIV Pathogenesis Dr Sharana Mahomed writes for @SpringerNature "A World AIDS Day Journey with Broadly Neutralizing Antibodies: Behind Our Review" https://t.co/5WOcpoaNI9 #HIV #bNAb #sciencenews #WorldAidsDay2025

0

3

1

0

135

Antonio Guerrero @guerreroespejo

12 months ago

La combinación de lenacapavir (LEN, Gilead) y dos anticuerpos ampliamente neutralizantes (#bNAb) podría ser una buena opción para el tratamiento del #VIH en ciertos pacientes, según los resultados de un ensayo de fase 2 presentado en EACS 2025, en París. https://t.co/QA9oPhayJl

0

7

2

1

1K

Emi E. Nakayama　MD, PhD @EmiNakayama7

almost 2 years ago

♪それは秘密ひみつ秘密秘密のsomatic hypermutation （論文その１３） #redirection #bnAb https://t.co/SshIVx6HGB

1

45

8

16

0

Wits RHI @WitsRHI

about 2 years ago

🚨Don’t miss this key oral session at #HIVR4P2024! Discover the Phase 1 trial (HVTN140/HPTN101) evaluating the safety and neutralization activity of #bNAb combinations for #HIVprevention. Wits RHI is proud to contribute to this groundbreaking research! 🔗https://t.co/e6opvBR0dm

WitsRHI's tweet photo. 🚨Don’t miss this key oral session at #HIVR4P2024! Discover the Phase 1 trial (HVTN140/HPTN101) evaluating the safety and neutralization activity of #bNAb combinations for #HIVprevention. Wits RHI is proud to contribute to this groundbreaking research!

🔗https://t.co/e6opvBR0dm https://t.co/mrlya1UXSv

0

3

0

157

African Alliance

@Afri_Alliance

about 2 years ago

[THREAD] Are you missing out on #HIVR4P? We've got you. We'll be covering a number of sessions we think are relevant for communities. Follow along to hear about the importance of including communities early on in #bnAb trials, starting right now.

1

4

2

0

414

RIOtrial @RIOtrial

about 2 years ago

#AIDS2024 @PennyZach1 and @jnim87 present their poster comparing #BNAB sensitivity prediction outcomes using blood or gut proviral DNA and rebound plasma RNA in people treated during primary HIV infection.

RIOtrial's tweet photo. #AIDS2024

@PennyZach1 and @jnim87 present their poster comparing #BNAB sensitivity prediction outcomes using blood or gut proviral DNA and rebound plasma RNA in people treated during primary HIV infection. https://t.co/mgb4jR9zqc

0

9

2

0

631

Jillian Lau @JillianLau1

about 2 years ago

Similar sensitivity results between plasma RNA testing and proviral DNA testing, demonstrating that using proviral DNA is an option to screen for bNAb resistance. Baseline resistance screening is a big issue in #bNAb trials so it’s good to have more options!

JillianLau1's tweet photo. Similar sensitivity results between plasma RNA testing and proviral DNA testing, demonstrating that using proviral DNA is an option to screen for bNAb resistance.

Baseline resistance screening is a big issue in #bNAb trials so it’s good to have more options! https://t.co/oZLAxTAG48

0

2

0

226

Jillian Lau @JillianLau1

about 2 years ago

More #HIVcure posters at #AIDS2024 #bNAb sensitivity testing in the @RIOtrial of long-acting 3BNC-117 and 10-1074 in PLWHIV started on ART in acute infection. Proviral DNA on ART and plasma RNA at time of viral rebound was tested using NIH or Rockerfeller models.

JillianLau1's tweet photo. More #HIVcure posters at #AIDS2024

#bNAb sensitivity
testing in the @RIOtrial of long-acting 3BNC-117 and 10-1074 in PLWHIV started on ART in acute infection. Proviral DNA on ART and plasma RNA at time of viral rebound was tested using NIH or Rockerfeller models. https://t.co/bEtykw0jWa

1

14

3

2

1K

AVAC @HIVpxresearch

over 2 years ago

This week @IAVI hosted a CASPR research literacy workshop in Nairobi. Participants learned about current #HIV vaccine and #bNAb research approaches and discussed the importance of advocacy and community engagement in the long road of HIV vaccine discovery.

HIVpxresearch's tweet photo. This week @IAVI hosted a CASPR research literacy workshop in Nairobi. Participants learned about current #HIV vaccine and #bNAb research approaches and discussed the importance of advocacy and community engagement in the long road of HIV vaccine discovery. https://t.co/rXAoH3mNO5

1

18

5

0

546

AVAC @HIVpxresearch

almost 3 years ago

Thank you @iasociety for hosting an important discussion on #bNAbs this #HIVR4P! To learn more, check out AVAC's infographic exploring the relationship between broadly neutralizing antibodies (#bNAb) and HIV here! https://t.co/6tk2D33x2O

HIVpxresearch's tweet photo. Thank you @iasociety for hosting an important discussion on #bNAbs this #HIVR4P! To learn more, check out AVAC's infographic exploring the relationship between broadly neutralizing antibodies (#bNAb) and HIV here! https://t.co/6tk2D33x2O https://t.co/HLIVYiSWjw

0

10

4

0

1K

AVAC @HIVpxresearch

almost 3 years ago

.@iasociety #HIVR4P webinar "The future of bNAbs" is live and we're getting the latest in #bNAb research: From @FKlein_Lab, ""bNAb mediated prevention can work. But better antibodies are needed".

HIVpxresearch's tweet photo. .@iasociety #HIVR4P webinar "The future of bNAbs" is live and we're getting the latest in #bNAb research: From @FKlein_Lab, ""bNAb mediated prevention can work. But better antibodies are needed". https://t.co/4eWEPD4SjF

1

2

0

366

INSERM U1259 "VIH et Hépatites" @Inserm_U1259

about 3 years ago

#Postdoctoral position in Virology in France Post-doctoral position available in our lab @Inserm_U1259, to study #HIV and neutralizing antibodies #bNAb. Looking for #postdoc with interest in #virology #immunology @Inserm @agenceANRS @SFV_France @ESCVirology please get the msg out

Inserm_U1259's tweet photo. #Postdoctoral position in Virology in France
Post-doctoral position available in our lab @Inserm_U1259, to study #HIV and neutralizing antibodies #bNAb. Looking for #postdoc with interest in #virology #immunology
@Inserm @agenceANRS @SFV_France @ESCVirology please get the msg out https://t.co/xCZ2m0i9PL

1

24

21

2

6K

Cell Host & Microbe @cellhostmicrobe

about 3 years ago

Controlling #HIV: @Luis_Mab @MOUQUETHugo1 ID B cell lineage of broadly neutralizing antibodies in HIV-1 post-treatment controller. Circulating viruses escaped #bNAb pressure but remained sensitive to autologous neutralization by other antibody populations https://t.co/Pn6SMTUIds

cellhostmicrobe's tweet photo. Controlling #HIV: @Luis_Mab @MOUQUETHugo1 ID B cell lineage of broadly neutralizing antibodies in HIV-1 post-treatment controller. Circulating viruses escaped #bNAb pressure but remained sensitive to autologous neutralization by other antibody populations https://t.co/Pn6SMTUIds https://t.co/XuNZd0oVQJ

0

7

4

0

2K

IAS - the International AIDS Society

@iasociety

about 3 years ago

"The current effort is to induce #bnAb precursors with broadly reactive autologous neutralizing activity." - @DukeU's Barton Haynes 🇺🇸 #IAS2023

0

1

0

336

Jillian Lau @JillianLau1

about 3 years ago

Katie summarises the data from previous early single #bNAb studies, #combination bNAB studies, combos with vaccines & other immunotherapies, long acting formulations, and bNABs given early in #HIV infection. Including studies that are currently being done/analysed & to watch for

1

0

284

Jillian Lau @JillianLau1

about 3 years ago

She explains the pros and cons of #bNAb Phenosense screening assay - a regular discussion as approx 50% ppl screen out of trials due to having virus that isn’t sensitive to the tested bNAb. More assays & antibodies are being developed which will advance the field

JillianLau1's tweet photo. She explains the pros and cons of #bNAb Phenosense screening assay - a regular discussion as approx 50% ppl screen out of trials due to having virus that isn’t sensitive to the tested bNAb.
More assays & antibodies are being developed which will advance the field https://t.co/wtgNy864Z3

1

2

1

0

212

Jillian Lau @JillianLau1

about 3 years ago

#IAS2023 Wilton Williams from Duke takes us through the development of MPER broadly neutralising antibodies #bNAb. These are being developed for #HIV #vaccine clinical trials. We are seeing an explosion of bNAb technologies in HIV #treatment #precention and #cure.

JillianLau1's tweet photo. #IAS2023 Wilton Williams from Duke takes us through the development of MPER broadly neutralising antibodies #bNAb. These are being developed for #HIV #vaccine clinical trials. We are seeing an explosion of bNAb technologies in HIV #treatment #precention and #cure. https://t.co/rJ7MAMLEuV

1

20

5

1

2K

Top Tweets for #BnAB

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users